The Enhanced International Prognostic Index for Diffuse Large B‐cell Lymphoma | Semantic Scholar
CT-Based Versus FDG-PET/CT–Based NCCN International Prognostic Index Risk Stratification in DLBCL in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 2 (2015)
Comparison of factors and scoring of IPI, NCCN-IPI, and GELTAMO-IPI | Download Table
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study | JCO Clinical Cancer Informatics
Comparison of classic IPI, NCCN-IPI, and modified prognostic model for... | Download Table
Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma
Frontiers | Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study
Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14 | PLOS ONE
Improving the Prognostic Index for Diffuse Large B-Cell Lymphoma
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study | JCO Clinical Cancer Informatics
Table 1 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Videomed
KoreaMed Synapse
Table 4 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. - Abstract - Europe PMC
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
Immunohistochemical double hit score enhances NCCN–IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma - Prochazka - 2018 - British Journal of Haematology -
Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma
Five-year OS for low vs high NCCN-IPI risk groups (A) and according to... | Download Scientific Diagram
Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to Management?
The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study | Cancer Cell International | Full Text
We applied the model of (A) NCCN-IPI in our study. Compared with (B)... | Download Scientific Diagram
Age cutoffs for the conventional IPI, NCCN-IPI, and GELTAMO-IPI | Download Scientific Diagram
Validation of the International Prognostic Index and Subsequent Revisions for Diffuse Large B-Cell Lymphoma in Patients From the
EHA Library - The official digital education library of European Hematology Association (EHA)
